The DOI matches its OpenAlex record; 63 of the 63 references it cites were found in a registry or an index.
Long-term Effects of Antihypertensive Agents on Proteinuria and Renal Function
Abstract
BACKGROUND: Although many studies have examined the effects of antihypertensive agents on proteinuria and glomerular filtration rate in patients with kidney disease, many questions remain unresolved. These questions include whether the effects of agents differ, whether their effects are similar in diabetic and nondiabetic patients with renal disease, and whether the effects of any agents are independent of blood pressure reductions. METHODS: We conducted a meta-analysis of studies obtained with MEDLINE and bibliographies from comprehensive reviews but included only investigations with follow-up times of at least 6 months. We combined data (1) in an analysis of randomized controlled trials, (2) in a separate univariate analysis of controlled and uncontrolled trials, and (3) using weighted multiple linear regression. RESULTS: In 14 randomized controlled trials, angiotensin-converting enzyme inhibitors caused a greater decrease in proteinuria (pooled mean [95% confidence intervals], -0.51[-0.68 to -0.35], ln [treatment/control]), improvement in glomerular filtration rate (0.13 mL/min per month [0.10 to 0.16 mL/min per month]), and decline in mean arterial pressure (-4.0 mm Hg [-4.9 to -3.0 mm Hg]) compared with controls. In a multivariate analysis of controlled and uncontrolled trials, each 10-mm Hg reduction in blood pressure decreased proteinuria (regression coefficient [95% confidence interval] -0.14 [-0.22 to -0.06] ln [after/before]), but angiotensin-converting enzyme inhibitors (-0.45 [-0.58 to -0.32]) and nondihydropyridine calcium antagonists (-0.38 [-0.70 to -0.06]) were associated with additional declines in proteinuria that were independent of blood pressure changes and diabetes. Each 10-mm Hg reduction in blood pressure caused a relative improvement in glomerular filtration rate (0.18 mL/min per month [0.04 to 0.31 mL/min per month]), but among diabetic patients there was a tendency for dihydropyridine calcium antagonists to cause a relative reduction in glomerular filtration rate (-0.68 mL/min per month [-1.31 to -0.04 mL/min per month]). CONCLUSIONS: Long-term beneficial effects of antihypertensive agents on proteinuria and glomerular filtration rate are proportional to blood pressure reductions and are similar in diabetic and nondiabetic patients with renal disease. In addition, angiotensin-converting enzyme inhibitors, and possibly nondihydropyridine calcium antagonists, have additional beneficial effects on proteinuria that are independent of blood pressure reductions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Multiple imputation in health‐are databases: An overview and some applications
Rubin, D. B., & Schenker, N. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100410 · Cited by 1,550
Ravid, M., Savin, H., Jutrin, I., Bental, T., Katz, B., & Lishner, M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-8-199304150-00001 · Cited by 775
Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy
Mogensen, C. E. (1982) · BMJ · doi:10.1136/bmj.285.6343.685 · Cited by 760
Kasiske, B. L., Kalil, R. S. N., Ma, J. Z., Liao, M., & Keane, W. F. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-2-199301150-00009 · Cited by 594
Effect of antihypertensive treatment on kidney function in diabetic nephropathy.
Parving, H. H., Andersen, A. R., Smidt, U. M., Hommel, E., Mathiesen, E. R., & Svendsen, P. A. (1987) · BMJ · doi:10.1136/bmj.294.6585.1443 · Cited by 537
Mathiesen, E. R., Hommel, E., Giese, J., & Parving, H. H. (1991) · BMJ · doi:10.1136/bmj.303.6794.81 · Cited by 464
(1994) · Cited by 463
Effect of aging on plasma renin and aldosterone in normal man
Weidmann, P., De Myttenaere-Bursztein, S., Maxwell, M. H., & de Lima, J. (1975) · Kidney International · doi:10.1038/ki.1975.120 · Cited by 440
Renal protective effect of enalapril in diabetic nephropathy.
Bjorck, S., Mulec, H., Johnsen, S. A., Norden, G., & Aurell, M. (1992) · BMJ · doi:10.1136/bmj.304.6823.339 · Cited by 432
Bjorck, S., Nyberg, G., Mulec, H., Granerus, G., Herlitz, H., & Aurell, M. (1986) · BMJ · doi:10.1136/bmj.293.6545.471 · Cited by 405
Viberti, G. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510280037029 · Cited by 381
Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
Marre, M., Chatellier, G., Leblanc, H., Guyene, T. T., Menard, J., & Passa, P. (1988) · BMJ · doi:10.1136/bmj.297.6656.1092 · Cited by 373
Senescence and the Renal Vasculature in Normal Man
HOLLENBERG, N. K., ADAMS, D. F., SOLOMON, H. S., RASHID, A., ABRAMS, H. L., & MERRILL, J. P. (1974) · Circulation Research · doi:10.1161/01.res.34.3.309 · Cited by 370
Parving, H. H., Hommel, E., & Smidt, U. M. (1988) · BMJ · doi:10.1136/bmj.297.6656.1086 · Cited by 328
Fekety, R., Silva, J., Kauffman, C., Buggy, B., & Gunner Deery, H. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90223-4 · Cited by 293
Long-term comparison between captopril and nifedipine in the progression of renal insufficiency
Zucchelli, P., Zuccalà, A., Borghi, M., Fusaroli, M., Sasdelli, M., Stallone, C., Sanna, G., & Gaggi, R. (1992) · Kidney International · doi:10.1038/ki.1992.309 · Cited by 270
Effect of aging on renin activity and aldosterone excretion.
Crane, M. G., & Harris, J. (1976) · PubMed · Cited by 239
Treatment of arterial hypertension in diabetic humans: Importance of therapeutic selection
Bakris, G. L., Barnhill, B. W., & Sadler, R. (1992) · Kidney International · doi:10.1038/ki.1992.139 · Cited by 219
Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.
Lebovitz, H. E., Wiegmann, T. B., Cnaan, A., Shahinfar, S., Sica, D. A., Broadstone, V. L., Schwartz, S. L., Mengel, M. C., Segal, R., & Versaggi, J. A. (1994) · PubMed · Cited by 219
Martin, M., Neumann, D., Hoff, T., Resch, K., DeWitt, D. L., & Goppelt-Struebe, M. (1994) · Kidney International · doi:10.1038/ki.1994.18 · Cited by 178
Parving, H. H., Hommel, E., Damkjaer Nielsen, M., & Giese, J. (1989) · BMJ · doi:10.1136/bmj.299.6698.533 · Cited by 171
Effect of Enalapril on the Progression of Chronic Renal Failure
Kamper, A.-L., Strandgaard, S., & Leyssac, P. P. (1992) · American Journal of Hypertension · doi:10.1093/ajh/5.7.423 · Cited by 163
Slataper, R., Vicknair, N., Sadler, R., & Bakris, G. L. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410080037006 · Cited by 139
Chan, J. C. N., Cockram, C. S., Nicholls, M. G., Cheung, C. K., & Swaminathan, R. (1992) · BMJ · doi:10.1136/bmj.305.6860.981 · Cited by 135
Praga, M., Hernández, E., Montoyo, C., Andrés, A., Ruilope, L. M., & Rodicio, J. L. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80696-2 · Cited by 132
Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.
Lacourcière, Y., Nadeau, A., Poirier, L., & Tancrède, G. (1993) · Hypertension · doi:10.1161/01.hyp.21.6.786 · Cited by 117
Rudberg, S. L., Aperia, A. C., FREYSCHUSS, U., & Persson, B. (1990) · Diabetologia · doi:10.1007/bf00405108 · Cited by 114
Higher blood pressure in adults with less education. Some explanations from INTERSALT.
Stamler, R., Shipley, M. J., Elliott, P., Dyer, A. R., Sans, S., & Stamler, J. F. (1992) · Hypertension · doi:10.1161/01.hyp.19.3.237 · Cited by 101
Hallab, M., Gallois, Y., Châtellier, G., Rohmer, V., Fressinaud, P., & Marre, M. (1993) · BMJ · doi:10.1136/bmj.306.6871.175 · Cited by 78
Cardiovascular and Renal Effects of Long-term Antihypertensive Treatment
Hartford, M. (1988) · JAMA · doi:10.1001/jama.1988.03720170029028 · Cited by 77
Albuminuria vs urinary total protein for detecting chronic renal disorders
Shihabi, Z. K., KONEN, J. C., & O'Connor, M. L. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.5.621 · Cited by 76
Ferder, L., Daccordi, H., Martello, M., Panzalis, M., & Inserra, F. (1992) · Hypertension · doi:10.1161/01.hyp.19.2_suppl.ii237 · Cited by 75
Renal Protective Effect of Strict Blood Pressure Control With Enalapril Therapy
Bauer, J. H. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370080033008 · Cited by 69
Bauer, J. H., Reams, G. P., Hewett, J. E., Klachko, D. M., Lau, A., Messina, C. R., & Knaus, V. L. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70256-1 · Cited by 69
Bakris, G. L., Slataper, R., Vicknair, N., & Sadler, R. (1994) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(94)90003-5 · Cited by 67
Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy.
Parving, H. ‐., Andersen, A., Hommel, E. E., & Smidt, U. (1985) · Hypertension · doi:10.1161/01.hyp.7.6_pt_2.ii114 · Cited by 59
Oral calcium supplementation and blood pressure: an overview of randomized controlled trials
Cappuccio, F. P., Siani, A., & Strazzullo, P. (1989) · Journal of Hypertension · doi:10.1097/00004872-198912000-00003 · Cited by 58
Passa, P., Leblanc, H., & Marre, M. (1987) · Diabetes Care · doi:10.2337/diacare.10.2.200 · Cited by 54
Parving, H., Andersen, A. R., Smidt, U., et al. (1981) · Diabetes Care · doi:10.2337/diacare.4.4.459 · Cited by 48
Romero, R., Salinas, I., Lucas, A., Abad, E., Reverter, J. L., Johnston, S., & Sanmartí, A. (1993) · Diabetes Care · doi:10.2337/diacare.16.4.597 · Cited by 45
Bianchi, S., Bigazzi, R., Baldari, G., & Campese, V. M. (1991) · American Journal of Nephrology · doi:10.1159/000168289 · Cited by 43
Jerums, G., Allen, T. J., Tsalamandris, C., & Cooper, M. E. (1992) · Kidney International · doi:10.1038/ki.1992.138 · Cited by 39
Bigazzi, R., Bianchi, S., Baldari, D., Sgherri, G., Baldari, G., & Campese, V. M. (1993) · American Journal of Hypertension · doi:10.1093/ajh/6.2.108 · Cited by 37
Romero, R., Salinas, I., Lucas, A., Teixidó, J., Audı́, L., & Sanmartı́, A. (1992) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(92)90094-8 · Cited by 35
Abraham, P. A. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.11.2358 · Cited by 34
Stornello, M., Valvo, E. V., & Scapellato, L. (1992) · Clinical Science · doi:10.1042/cs0820019 · Cited by 30
Hermans, M. P., Brichard, S. M., Colin, I. M., Borgies, P., Ketelslegers, J., & Lambert, A. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90158-8 · Cited by 29
Effects of Atenolol and Enalapril on Kidney Function in Hypertensive Diabetic Patients
Cesaris, R. D., Ranieri, G., Filitti, V., Andriani, A., & Bonfantino, M. V. (1993) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199308000-00006 · Cited by 27
Renal hemodynamic changes during long-term antihypertensive therapy
Warren, S. E., O’Connor, D. T., Cohen, I. M., & Mitas, J. A. (1981) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1981.41 · Cited by 27
Antihypertensive therapy in experimental diabetes.
Anderson, S. (1992) · Journal of the American Society of Nephrology · doi:10.1681/asn.v34s86 · Cited by 26
Stornello, M., Valvo, E. V., Vasques, E., Leone, S., & Scapellato, L. (1989) · Journal of Hypertension · doi:10.1097/00004872-198909007-00016 · Cited by 26
Parving, H.-H., & Smidt, U. M. (1986) · Diabetic Medicine · doi:10.1111/j.1464-5491.1986.tb00770.x · Cited by 24
Publication bias: Its implications for clinical pharmacology
Levy, G. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.119 · Cited by 19
Effect of Lisinopril Monotherapy on Renal Hemodynamics
Reams, G. P., & Bauer, J. H. (1988) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(88)80086-6 · Cited by 17
Okamura, M., Kanayama, Y., Negoro, N., Inoue, T., & Takeda, T. (2015) · Contributions to nephrology · doi:10.1159/000420139 · Cited by 17
Eliahou, H. E., Cohen, D., Ben-David, A., Herzog, D., Serban, I., Gavendo, S., Kapuler, S., Kogan, N., & Hellberg, B. (1988) · Cardiovascular Drugs and Therapy · doi:10.1007/bf02125735 · Cited by 10
Reams, G. P., Lau, A., Knaus, V. L., et al. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb04668.x · Cited by 10
Strandgaard, S., Elmgreen, J., Christensen, T. E., & Sw, L. (1982) · PubMed · Cited by 8
Antihypertensive Effect of Nitrendipine in the Hypertensive Patient with Renal Impairment
Ruilope, L. M., Araque, A., Lahera, V., & Suárez, C. R. (1993) · Renal Failure · doi:10.3109/08860229309054945 · Cited by 6
Effects of captopril on diabetic nephropathy in hypertensive women
de Llamas, L. G.-S., Alberola, A. G., López-Herrera, M. L., Jimenez, T. F., Pardo, J. F., & Cascales, J. H. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00626360 · Cited by 5
Piccoli, A., Favaro, E., Piva, M., Bisetto, F., Calzavara, P., Arduini, R., Nordio, M., Stoppa, F., Roncali, D., & Pillon, L. (1993) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80790-8 · Cited by 5
Cited by
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Effect of lipid reduction on the progression of renal disease: A meta-analysis
Fried, L. F., Orchard, T. J., & Kasiske, B. L. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00487.x · Cited by 672
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
KASISKE, B. L., VAZQUEZ, M. A., HARMON, W. E., BROWN, R. S., DANOVITCH, G. M., GASTON, R. S., ROTH, D., SCANDLING, J. D., & SINGER, G. G. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11suppl_1s1 · Cited by 634
Early recognition and prevention of chronic kidney disease
James, M. T., Hemmelgarn, B. R., & Tonelli, M. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62004-3 · Cited by 606
Messerli, F. H., Grossman, E., & Goldbourt, U. (1998) · JAMA · doi:10.1001/jama.279.23.1903 · Cited by 561
Metadata
- Authors
- Maki, D. D.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association
- Published
- 1995-05-22
- Volume
- 155
- Issue
- 10
- Pages
- 1073-1073
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2114646524
- Cited by
- 273
- References
- 63
- FWCI
- 22.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.